Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,100 | -365,900 | -358,000 | -330,600 | -100 |
| Depreciation Amortization | 17,900 | 373,100 | 357,800 | 345,200 | 14,400 |
| Income taxes - deferred | N/A | 100 | 0 | 0 | N/A |
| Accounts receivable | -8,700 | 6,200 | 3,600 | -15,400 | 800 |
| Accounts payable and accrued liabilities | 5,400 | -1,400 | 2,800 | 3,600 | 0 |
| Other Working Capital | -8,200 | -19,300 | -17,700 | -39,100 | -12,100 |
| Other Operating Activity | 12,000 | 9,000 | 2,700 | 6,400 | -19,300 |
| Operating Cash Flow | $-15,700 | $1,800 | $-8,800 | $-29,900 | $-16,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,400 | -15,600 | -10,900 | -8,100 | -5,300 |
| Purchase Sale Intangibles | -1,100 | -11,800 | -10,500 | -7,100 | -3,000 |
| Other Investing Activity | -1,100 | -11,800 | -10,500 | -7,100 | -3,000 |
| Investing Cash Flow | $-6,500 | $-27,400 | $-21,400 | $-15,200 | $-8,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 165,000 | 165,000 | 40,000 | 40,000 |
| Debt Repayment | -100 | -80,500 | -80,800 | -20,700 | -20,600 |
| Common Stock Issued | N/A | 3,300 | 2,700 | 2,700 | N/A |
| Other Financing Activity | -2,900 | -23,600 | -14,500 | -5,800 | -5,800 |
| Financing Cash Flow | $-3,000 | $64,200 | $72,400 | $16,200 | $13,600 |
| Exchange Rate Effect | -100 | 800 | 700 | 700 | 100 |
| Beginning Cash Position | 151,300 | 111,900 | 111,900 | 111,900 | 111,900 |
| End Cash Position | 126,000 | 151,300 | 154,800 | 83,700 | 101,000 |
| Net Cash Flow | $-25,300 | $39,400 | $42,900 | $-28,200 | $-10,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,700 | 1,800 | -8,800 | -29,900 | -16,300 |
| Capital Expenditure | -5,400 | -15,600 | -10,900 | -8,100 | -5,300 |
| Free Cash Flow | -21,100 | -13,800 | -19,700 | -38,000 | -21,600 |